Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
VirnetX loses rulings in patents case with Apple, Bloomberg reports » 14:56
07/14/20
07/14
14:56
07/14/20
14:56
VHC

VirnetX

$5.82 /

-0.44 (-7.03%)

, AAPL

Apple

$385.69 /

+3.67 (+0.96%)

VirnetX's (VHC)…

VirnetX's (VHC) '135 and '151 patents were invalidated in an agency review in the company's patent case against Apple (AAPL), according to Bloomberg.

ShowHide Related Items >><<
VHC VirnetX
$5.82 /

-0.44 (-7.03%)

AAPL Apple
$385.69 /

+3.67 (+0.96%)

VHC VirnetX
$5.82 /

-0.44 (-7.03%)

AAPL Apple
$385.69 /

+3.67 (+0.96%)

07/13/20 Wedbush
Wedbush boosts Apple target to $450 ahead of 'massive' iPhone cycle
07/13/20 KeyBanc
Data indicates 'strong recovery' in Apple iPhone sales, says KeyBanc
07/13/20 Morgan Stanley
Apple price target raised to $419 from $340 at Morgan Stanley
07/09/20 Nomura Instinet
Nomura says Apple iPhone shipments in China pressured by 5G models in June
AAPL Apple
$385.69 /

+3.67 (+0.96%)

VHC VirnetX
$5.82 /

-0.44 (-7.03%)

AAPL Apple
$385.69 /

+3.67 (+0.96%)

VHC VirnetX
$5.82 /

-0.44 (-7.03%)

AAPL Apple
$385.69 /

+3.67 (+0.96%)

VHC VirnetX
$5.82 /

-0.44 (-7.03%)

AAPL Apple
$385.69 /

+3.67 (+0.96%)

AAPL Apple
$385.69 /

+3.67 (+0.96%)

Options
Smith and Wesson call volume above normal and directionally bullish » 14:45
07/14/20
07/14
14:45
07/14/20
14:45
SWBI

Smith & Wesson Brands

$21.79 /

+1.93 (+9.72%)

Bullish option flow…

Bullish option flow detected in Smith and Wesson with 9,536 calls trading, 1.1x expected, and implied vol increasing over 3 points to 83.10%. Jul-20 22.5 calls and Jan-21 27 calls are the most active options, with total volume in those strikes near 3,800 contracts. The Put/Call Ratio is 0.06. Earnings are expected on August 27th.

ShowHide Related Items >><<
SWBI Smith & Wesson Brands
$21.79 /

+1.93 (+9.72%)

SWBI Smith & Wesson Brands
$21.79 /

+1.93 (+9.72%)

07/08/20 Lake Street
Smith & Wesson Brands price target raised to $28 from $24 at Lake Street
06/30/20 Spin-Off Research
Smith & Wesson Brands initiated with a Buy at Spin-Off Research
06/19/20 Lake Street
Smith & Wesson Brands price target raised to $24 from $19 at Lake Street
06/11/20 Wedbush
Smith & Wesson Brands price target raised to $18 from $8.50 at Wedbush
SWBI Smith & Wesson Brands
$21.79 /

+1.93 (+9.72%)

SWBI Smith & Wesson Brands
$21.79 /

+1.93 (+9.72%)

SWBI Smith & Wesson Brands
$21.79 /

+1.93 (+9.72%)

SWBI Smith & Wesson Brands
$21.79 /

+1.93 (+9.72%)

Recommendations
LVMH price target raised to EUR 470 from EUR 445 at Morgan Stanley » 11:58
07/14/20
07/14
11:58
07/14/20
11:58
LVMUY

LVMH

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Morgan Stanley analyst Edouard Aubin raised the firm's price target on LVMH to EUR 470 from EUR 445 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
LVMUY LVMH
$0.00 /

+ (+0.00%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

06/24/20 Morgan Stanley
LVMH price target raised to EUR 445 from EUR 440 at Morgan Stanley
06/05/20 Societe Generale
SocGen backs Buy on LVMH after Tiffany statement
06/05/20 Societe Generale
Societe Generale still sees LVMH going through with deal for Tiffany
06/03/20 RBC Capital
LVMH price target raised to EUR 400 from EUR 390 at RBC Capital
LVMUY LVMH
$0.00 /

+ (+0.00%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

On The Fly
Netflix downgrade, Wayfair upgrade among today's top calls on Wall Street » 10:16
07/14/20
07/14
10:16
07/14/20
10:16
NFLX

Netflix

$509.99 /

-14.64 (-2.79%)

, W

Wayfair

$211.00 /

+0.15 (+0.07%)

, SPOT

Spotify

$250.00 /

-11.11 (-4.25%)

, HOG

Harley-Davidson

$26.53 /

+0.55 (+2.12%)

, SQ

Square

$114.80 /

-3.84 (-3.24%)

, MA

MasterCard

$291.01 /

+0.81 (+0.28%)

, V

Visa

$188.70 /

-0.27 (-0.14%)

, EEFT

Euronet

$94.73 /

-0.86 (-0.90%)

, WU

Western Union

$21.37 /

-0.115 (-0.54%)

, PAYX

Paychex

$70.88 /

-0.73 (-1.02%)

, ADP

ADP

$142.95 /

-2.57 (-1.77%)

, WEX

Wex

$149.65 /

-3.44 (-2.25%)

, FLT

FleetCor

$246.19 /

-2.13 (-0.86%)

, LPRO

Open Lending

$16.21 /

+0.54 (+3.45%)

, EVOP

EVO Payments

$20.83 /

-0.27 (-1.28%)

, GPN

Global Payments

$159.81 /

-0.91 (-0.57%)

, FIS

FIS

$134.58 /

-0.89 (-0.66%)

, FISV

Fiserv

$95.45 /

+1.17 (+1.24%)

, EVTC

Evertec

$26.64 /

+ (+0.00%)

Check out today's top…

Open Full Text

ShowHide Related Items >><<
WU Western Union
$21.37 /

-0.115 (-0.54%)

WEX Wex
$149.65 /

-3.44 (-2.25%)

W Wayfair
$211.00 /

+0.15 (+0.07%)

V Visa
$188.70 /

-0.27 (-0.14%)

SQ Square
$114.80 /

-3.84 (-3.24%)

SPOT Spotify
$250.00 /

-11.11 (-4.25%)

PAYX Paychex
$70.88 /

-0.73 (-1.02%)

NFLX Netflix
$509.99 /

-14.64 (-2.79%)

MA MasterCard
$291.01 /

+0.81 (+0.28%)

HOG Harley-Davidson
$26.53 /

+0.55 (+2.12%)

GPN Global Payments
$159.81 /

-0.91 (-0.57%)

FLT FleetCor
$246.19 /

-2.13 (-0.86%)

FISV Fiserv
$95.45 /

+1.17 (+1.24%)

FIS FIS
$134.58 /

-0.89 (-0.66%)

EVTC Evertec
$26.64 /

+ (+0.00%)

EVOP EVO Payments
$20.83 /

-0.27 (-1.28%)

EEFT Euronet
$94.73 /

-0.86 (-0.90%)

ADP ADP
$142.95 /

-2.57 (-1.77%)

NFLX Netflix
$509.99 /

-14.64 (-2.79%)

07/14/20
Fly Intel: Top five analyst downgrades
07/14/20 Wedbush
Netflix price target raised to $220 from $198 at Wedbush
07/14/20 Barclays
Netflix price target raised to $550 from $420 at Barclays
07/14/20
Netflix downgraded to Neutral at UBS on valuation, tougher comps in 2021
W Wayfair
$211.00 /

+0.15 (+0.07%)

07/14/20
Fly Intel: Top five analyst upgrades
07/14/20 Wedbush
Wayfair upgraded to Outperform at Wedbush
07/14/20 Wedbush
Wayfair upgraded to Outperform from Neutral at Wedbush
07/07/20 Baird
Wayfair price target raised to $225 from $190 at Baird
SPOT Spotify
$250.00 /

-11.11 (-4.25%)

07/14/20 UBS
Spotify double-downgraded to Sell from Buy at UBS
07/14/20 UBS
Spotify downgraded to Sell from Buy at UBS
07/13/20 BofA
Spotify price target raised to $357 from $185 at BofA
HOG Harley-Davidson
$26.53 /

+0.55 (+2.12%)

07/14/20 BMO Capital
Harley-Davidson upgraded to Outperform from Market Perform at BMO Capital
07/10/20
Fly Intel: Top five analyst upgrades
07/10/20 RBC Capital
Harley-Davidson upgraded to Sector Perform from Underperform at RBC Capital
SQ Square
$114.80 /

-3.84 (-3.24%)

07/14/20 Goldman Sachs
Square initiated with a Neutral at Goldman Sachs
07/09/20
Fly Intel: Top five analyst downgrades
07/09/20 Cowen
Square downgraded to Market Perform at Cowen
07/09/20 Cowen
Square downgraded to Market Perform from Outperform at Cowen
MA MasterCard
$291.01 /

+0.81 (+0.28%)

07/14/20 Goldman Sachs
MasterCard initiated with a Conviction Buy at Goldman Sachs
07/13/20 Wells Fargo
MasterCard price target raised to $335 from $325 at Wells Fargo
07/09/20 JPMorgan
MasterCard price target raised to $315 from $269 at JPMorgan
06/23/20 Wells Fargo
Finicity should help MasterCard with open banking efforts, says Wells Fargo
V Visa
$188.70 /

-0.27 (-0.14%)

07/14/20 Goldman Sachs
Visa initiated with a Buy at Goldman Sachs
07/13/20 Wells Fargo
Visa price target raised to $220 from $205 at Wells Fargo
07/09/20 JPMorgan
Visa price target raised to $203 from $182 at JPMorgan
06/23/20 Oppenheimer
MasterCard downgraded to Perform from Outperform at Oppenheimer
EEFT Euronet
$94.73 /

-0.86 (-0.90%)

07/14/20 Goldman Sachs
Euronet initiated with a Neutral at Goldman Sachs
06/19/20 Citi
Euronet downgraded to Neutral after faster than expected bounce at Citi
06/19/20 Citi
Euronet downgraded to Neutral from Buy at Citi
06/03/20 SunTrust
Euronet price target raised to $135 from $115 at SunTrust
WU Western Union
$21.37 /

-0.115 (-0.54%)

07/14/20 Goldman Sachs
Western Union initiated with a Sell at Goldman Sachs
07/01/20 Northland
Western Union upgraded to Outperform from Market Perform at Northland
06/10/20
Fly Intel: Top five analyst downgrades
06/10/20 BofA
Western Union downgraded to Neutral from Buy at BofA
PAYX Paychex
$70.88 /

-0.73 (-1.02%)

07/14/20 Goldman Sachs
Paychex initiated with a Sell at Goldman Sachs
07/08/20 BMO Capital
Paychex price target raised to $74 from $70 at BMO Capital
07/08/20 Citi
Paychex price target raised to $75 from $65 at Citi
07/07/20 Jefferies
Paychex price target raised to $75 from $68 at Jefferies
ADP ADP
$142.95 /

-2.57 (-1.77%)

07/14/20 Goldman Sachs
ADP initiated with a Sell at Goldman Sachs
05/18/20
Fly Intel: Top five analyst downgrades
05/18/20 BofA
ADP downgraded to Underperform on small business risk at BofA
05/18/20 BofA
ADP downgraded to Underperform from Neutral at BofA
WEX Wex
$149.65 /

-3.44 (-2.25%)

07/14/20 Goldman Sachs
Wex initiated with a Neutral at Goldman Sachs
05/28/20 Deutsche Bank
Wex price target raised to $172 from $150 at Deutsche Bank
05/07/20 BTIG
Wex price target lowered to $190 from $255 at BTIG
05/04/20 Baird
Wex price target raised to $152 from $132 at Baird
FLT FleetCor
$246.19 /

-2.13 (-0.86%)

07/14/20 Goldman Sachs
FleetCor initiated with a Buy at Goldman Sachs
07/09/20 Jefferies
Jefferies upgrades 'increasingly attractive' FleetCor to Buy from Hold
07/09/20 Jefferies
FleetCor upgraded to Buy from Hold at Jefferies
06/09/20 Cowen
FleetCor price target raised to $315 from $258 at Cowen
LPRO Open Lending
$16.21 /

+0.54 (+3.45%)

07/14/20 Goldman Sachs
Open Lending initiated with a Buy at Goldman Sachs
06/24/20 Northland
Open Lending price target raised to $20 from $15 at Northland
06/24/20 Canaccord
Open Lending helped by positive auto sector data points, says Canaccord
06/12/20 Canaccord
Canaccord starts financial technology Open Lending with a Buy
EVOP EVO Payments
$20.83 /

-0.27 (-1.28%)

07/14/20 Goldman Sachs
EVO Payments initiated with a Neutral at Goldman Sachs
06/05/20 Compass Point
EVO Payments price target raised to $22 from $16 at Compass Point
05/11/20 SunTrust
EVO Payments price target raised to $26 from $17 at SunTrust
05/11/20 Deutsche Bank
EVO Payments price target lowered to $29 from $33 at Deutsche Bank
GPN Global Payments
$159.81 /

-0.91 (-0.57%)

07/14/20 Goldman Sachs
Global Payments initiated with a Buy at Goldman Sachs
06/29/20 Oppenheimer
Global Payments price target raised to $202 from $190 at Oppenheimer
06/29/20 Oppenheimer
Fiserv downgraded to Perform at Oppenheimer
06/15/20 Argus
Global Payments initiated with a Buy at Argus
FIS FIS
$134.58 /

-0.89 (-0.66%)

07/14/20 Argus
FIS initiated with a Buy at Argus
07/14/20 Argus
FIS initiated with a Buy at Argus
07/14/20 Goldman Sachs
FIS initiated with a Buy at Goldman Sachs
07/07/20 Susquehanna
FIS margins should show sequential progress throughout year, says Susquehanna
FISV Fiserv
$95.45 /

+1.17 (+1.24%)

07/14/20 Barclays
Fiserv pullback brings 'unique buying opportunity,' says Barclays
07/14/20 Goldman Sachs
Fiserv initiated with a Conviction Buy at Goldman Sachs
06/29/20 Oppenheimer
Fiserv downgraded to Perform from Outperform at Oppenheimer
EVTC Evertec
$26.64 /

+ (+0.00%)

07/14/20 Goldman Sachs
Evertec initiated with a Neutral at Goldman Sachs
WU Western Union
$21.37 /

-0.115 (-0.54%)

WEX Wex
$149.65 /

-3.44 (-2.25%)

W Wayfair
$211.00 /

+0.15 (+0.07%)

V Visa
$188.70 /

-0.27 (-0.14%)

SQ Square
$114.80 /

-3.84 (-3.24%)

SPOT Spotify
$250.00 /

-11.11 (-4.25%)

PAYX Paychex
$70.88 /

-0.73 (-1.02%)

NFLX Netflix
$509.99 /

-14.64 (-2.79%)

MA MasterCard
$291.01 /

+0.81 (+0.28%)

HOG Harley-Davidson
$26.53 /

+0.55 (+2.12%)

GPN Global Payments
$159.81 /

-0.91 (-0.57%)

FLT FleetCor
$246.19 /

-2.13 (-0.86%)

FISV Fiserv
$95.45 /

+1.17 (+1.24%)

FIS FIS
$134.58 /

-0.89 (-0.66%)

EVTC Evertec
$26.64 /

+ (+0.00%)

EVOP EVO Payments
$20.83 /

-0.27 (-1.28%)

EEFT Euronet
$94.73 /

-0.86 (-0.90%)

ADP ADP
$142.95 /

-2.57 (-1.77%)

  • 05
    Dec
  • 13
    Aug
WU Western Union
$21.37 /

-0.115 (-0.54%)

W Wayfair
$211.00 /

+0.15 (+0.07%)

V Visa
$188.70 /

-0.27 (-0.14%)

SQ Square
$114.80 /

-3.84 (-3.24%)

SPOT Spotify
$250.00 /

-11.11 (-4.25%)

NFLX Netflix
$509.99 /

-14.64 (-2.79%)

MA MasterCard
$291.01 /

+0.81 (+0.28%)

HOG Harley-Davidson
$26.53 /

+0.55 (+2.12%)

FIS FIS
$134.58 /

-0.89 (-0.66%)

WU Western Union
$21.37 /

-0.115 (-0.54%)

W Wayfair
$211.00 /

+0.15 (+0.07%)

V Visa
$188.70 /

-0.27 (-0.14%)

SQ Square
$114.80 /

-3.84 (-3.24%)

SPOT Spotify
$250.00 /

-11.11 (-4.25%)

NFLX Netflix
$509.99 /

-14.64 (-2.79%)

MA MasterCard
$291.01 /

+0.81 (+0.28%)

HOG Harley-Davidson
$26.53 /

+0.55 (+2.12%)

FLT FleetCor
$246.19 /

-2.13 (-0.86%)

FISV Fiserv
$95.45 /

+1.17 (+1.24%)

FIS FIS
$134.58 /

-0.89 (-0.66%)

WU Western Union
$21.37 /

-0.115 (-0.54%)

W Wayfair
$211.00 /

+0.15 (+0.07%)

V Visa
$188.70 /

-0.27 (-0.14%)

SQ Square
$114.80 /

-3.84 (-3.24%)

SPOT Spotify
$250.00 /

-11.11 (-4.25%)

NFLX Netflix
$509.99 /

-14.64 (-2.79%)

MA MasterCard
$291.01 /

+0.81 (+0.28%)

HOG Harley-Davidson
$26.53 /

+0.55 (+2.12%)

FLT FleetCor
$246.19 /

-2.13 (-0.86%)

FISV Fiserv
$95.45 /

+1.17 (+1.24%)

FIS FIS
$134.58 /

-0.89 (-0.66%)

NFLX Netflix
$509.99 /

-14.64 (-2.79%)

Upgrade
Fly Intel: Top five analyst upgrades » 10:11
07/14/20
07/14
10:11
07/14/20
10:11
HOG

Harley-Davidson

$26.49 /

+0.51 (+1.96%)

, TSM

TSMC

$65.70 /

+0.62 (+0.95%)

, HBI

Hanesbrands

$11.84 /

+0.375 (+3.27%)

, DGX

Quest Diagnostics

$120.97 /

+1.9 (+1.60%)

, LH

LabCorp

$183.48 /

+5.17 (+2.90%)

, W

Wayfair

$208.07 /

-2.78 (-1.32%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Harley-Davidson (HOG) upgraded to Outperform from Market Perform at BMO Capital with analyst Gerrick Johnson saying he is more positive about the outlook for the company given recent management changes. 2. TSMC (TSM) upgraded to Buy from Outperform at CLSA with analyst Sebastian Hou citing his view that the company can "quickly" replace orders lost from Huawei with other clients. 3. Hanesbrands (HBI) upgraded to Outperform from Neutral at Credit Suisse with analyst Michael Binetti saying he thinks Hanesbrands weathered COVID-19 retail closures better than peers, with 50% of its store distribution remaining open during quarantine and a new $300M+ masks business offsetting factory deleverage in Q2. 4. Quest Diagnostics (DGX) and LabCorp (LH) were upgraded to Buy from Neutral at BofA. 5. Wayfair (W) upgraded to Outperform from Neutral at Wedbush with analyst Seth Basham saying amidst the coronavirus, consumers have shifted their spending to the home goods category and to the online channel, leaving Wayfair "perfectly positioned" to capture this spending. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
W Wayfair
$208.07 /

-2.78 (-1.32%)

TSM TSMC
$65.70 /

+0.62 (+0.95%)

LH LabCorp
$183.48 /

+5.17 (+2.90%)

HOG Harley-Davidson
$26.49 /

+0.51 (+1.96%)

HBI Hanesbrands
$11.84 /

+0.375 (+3.27%)

DGX Quest Diagnostics
$120.97 /

+1.9 (+1.60%)

HOG Harley-Davidson
$26.49 /

+0.51 (+1.96%)

07/14/20 BMO Capital
Harley-Davidson upgraded to Outperform from Market Perform at BMO Capital
07/10/20
Fly Intel: Top five analyst upgrades
07/10/20 RBC Capital
Harley-Davidson upgraded to Sector Perform from Underperform at RBC Capital
07/10/20 RBC Capital
Harley-Davidson upgraded to Sector Perform from Underperform at RBC Capital
TSM TSMC
$65.70 /

+0.62 (+0.95%)

07/13/20 CLSA
TSMC upgraded to Buy from Outperform at CLSA
04/28/20
Fly Intel: Top five analyst initiations
04/28/20 Wedbush
Wedbush bullish on TSMC, initiates with an Outperform
04/27/20 Wedbush
TSMC initiated with an Outperform at Wedbush
HBI Hanesbrands
$11.84 /

+0.375 (+3.27%)

07/14/20 Credit Suisse
Hanesbrands upgraded to Outperform from Neutral at Credit Suisse
07/14/20 Credit Suisse
Hanesbrands upgraded to Outperform from Neutral at Credit Suisse
06/24/20 B. Riley FBR
Hanesbrands products largely sold out at Walmart and Target, says B. Riley FBR
04/01/20
Fly Intel: Top five analyst initiations
DGX Quest Diagnostics
$120.97 /

+1.9 (+1.60%)

07/14/20 BofA
Quest Diagnostics upgraded to Buy from Neutral at BofA
07/14/20 BofA
Quest Diagnostics upgraded to Buy from Neutral at BofA
06/09/20 Wells Fargo
Quest Diagnostics upgraded to Equal Weight from Underweight at Wells Fargo
06/04/20 JPMorgan
LabCorp price target raised to $223 from $188 at JPMorgan
LH LabCorp
$183.48 /

+5.17 (+2.90%)

07/14/20 BofA
LabCorp upgraded to Buy from Neutral at BofA
07/14/20 BofA
LabCorp upgraded to Buy from Neutral at BofA
07/13/20 Wolfe Research
LabCorp upgraded to Outperform from Peer Perform at Wolfe Research
06/08/20 Baird
LabCorp price target raised to $219 from $199 at Baird
W Wayfair
$208.07 /

-2.78 (-1.32%)

07/14/20 Wedbush
Wayfair upgraded to Outperform at Wedbush
07/14/20 Wedbush
Wayfair upgraded to Outperform from Neutral at Wedbush
07/07/20 Baird
Wayfair price target raised to $225 from $190 at Baird
07/01/20 Deutsche Bank
Farfetch price target raised to $23 from $17 at Deutsche Bank
W Wayfair
$208.07 /

-2.78 (-1.32%)

TSM TSMC
$65.70 /

+0.62 (+0.95%)

LH LabCorp
$183.48 /

+5.17 (+2.90%)

HOG Harley-Davidson
$26.49 /

+0.51 (+1.96%)

HBI Hanesbrands
$11.84 /

+0.375 (+3.27%)

DGX Quest Diagnostics
$120.97 /

+1.9 (+1.60%)

W Wayfair
$208.07 /

-2.78 (-1.32%)

TSM TSMC
$65.70 /

+0.62 (+0.95%)

HOG Harley-Davidson
$26.49 /

+0.51 (+1.96%)

DGX Quest Diagnostics
$120.97 /

+1.9 (+1.60%)

W Wayfair
$208.07 /

-2.78 (-1.32%)

TSM TSMC
$65.70 /

+0.62 (+0.95%)

LH LabCorp
$183.48 /

+5.17 (+2.90%)

HOG Harley-Davidson
$26.49 /

+0.51 (+1.96%)

HBI Hanesbrands
$11.84 /

+0.375 (+3.27%)

DGX Quest Diagnostics
$120.97 /

+1.9 (+1.60%)

W Wayfair
$208.07 /

-2.78 (-1.32%)

TSM TSMC
$65.70 /

+0.62 (+0.95%)

HOG Harley-Davidson
$26.49 /

+0.51 (+1.96%)

HBI Hanesbrands
$11.84 /

+0.375 (+3.27%)

DGX Quest Diagnostics
$120.97 /

+1.9 (+1.60%)

Hot Stocks
ReviveMed announces AI-driven metabolomics study with Bristol Myers » 10:04
07/14/20
07/14
10:04
07/14/20
10:04
BMY

Bristol-Myers

$57.77 /

+0.015 (+0.03%)

ReviveMed announced that…

ReviveMed announced that it is pursuing an evaluation study with Bristol Myers Squibb. This study will leverage ReviveMed's artificial intelligence platform to better understand mechanisms of response and resistance to immunotherapies in patients with cancer. There is growing evidence of metabolites' role as regulators of biological activities and modifiers of other omics, including genomics. ReviveMed has built one of the most comprehensive databases about metabolites and their interactions with other molecules. Their proprietary AI algorithm utilizes this database for identifying a large number of metabolites for each patient quickly and at a low cost. ReviveMed's AI-driven platform translates these large number of data into finding novel disease mechanisms and molecules for drug discovery purposes.

ShowHide Related Items >><<
BMY Bristol-Myers
$57.77 /

+0.015 (+0.03%)

BMY Bristol-Myers
$57.77 /

+0.015 (+0.03%)

06/22/20 Morgan Stanley
Morgan Stanley sees Eliquis patent being upheld, ruling being 'imminent'
06/08/20 Bernstein
Gilead, AstraZeneca merger would make sense on economic basis, says Bernstein
06/02/20 Credit Suisse
Arena Pharmaceuticals price target raised to $87 from $77 at Credit Suisse
06/02/20 Cantor Fitzgerald
Arena Pharmaceuticals price target raised to $88 from $68 at Cantor Fitzgerald
BMY Bristol-Myers
$57.77 /

+0.015 (+0.03%)

BMY Bristol-Myers
$57.77 /

+0.015 (+0.03%)

BMY Bristol-Myers
$57.77 /

+0.015 (+0.03%)

BMY Bristol-Myers
$57.77 /

+0.015 (+0.03%)

Conference/Events
Jefferies Euro luxury retail analyst to hold analyst/industry conference call » 09:59
07/14/20
07/14
09:59
07/14/20
09:59
TIF

Tiffany

$121.20 /

-0.01 (-0.01%)

, LVMUY

LVMH

$0.00 /

+ (+0.00%)

European Luxury Retail…

European Luxury Retail Analyst Cereda, along with Michael Ward, Managing Director of Harrods, discuss Tiffany and LVMH's luxury market and spending trends on an Analyst/Industry conference call to be held on July 21 at 6 am.

ShowHide Related Items >><<
TIF Tiffany
$121.20 /

-0.01 (-0.01%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

TIF Tiffany
$121.20 /

-0.01 (-0.01%)

06/05/20 Societe Generale
SocGen backs Buy on LVMH after Tiffany statement
06/05/20 Societe Generale
Societe Generale still sees LVMH going through with deal for Tiffany
06/03/20 Credit Suisse
Tiffany could be worth $60-$75 if LVMH puts 'deal on ice,' says Credit Suisse
12/09/19 Cowen
Tiffany downgraded to Market Perform from Outperform at Cowen
LVMUY LVMH
$0.00 /

+ (+0.00%)

06/24/20 Morgan Stanley
LVMH price target raised to EUR 445 from EUR 440 at Morgan Stanley
06/03/20 RBC Capital
LVMH price target raised to EUR 400 from EUR 390 at RBC Capital
TIF Tiffany
$121.20 /

-0.01 (-0.01%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

TIF Tiffany
$121.20 /

-0.01 (-0.01%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

TIF Tiffany
$121.20 /

-0.01 (-0.01%)

LVMUY LVMH
$0.00 /

+ (+0.00%)

TIF Tiffany
$121.20 /

-0.01 (-0.01%)

Options
Notable open interest changes for July 14th » 08:55
07/14/20
07/14
08:55
07/14/20
08:55
AAPL

Apple

$382.02 /

-1.54 (-0.40%)

, TSLA

Tesla

$1,493.85 /

-53.69 (-3.47%)

, JPM

JPMorgan

$97.66 /

+1.35 (+1.40%)

, NIO

NIO Inc.

$13.85 /

-1.14 (-7.61%)

Monday's total…

Monday's total option volume of 35.5 million contracts resulted in net open interest growth of 4.48 million calls and 3.36 million puts. Apple (AAPL), Tesla (TSLA), JPMorgan (JPM) and NIO (NIO) saw the greatest growth. Top five new positions opened include 38k Snap Inc. (SNAP) 7/31 weekly 24.5 calls, 31k AT&T (T) Jul-20 29.5 puts, 20k Bed Bath & Beyond (BBBY) Jul-20 8 calls, 20k STMicroelectronics (STM) Aug-20 35 calls and 17k Nordic American Tankers (NAT) Aug-20 4.5 calls.

ShowHide Related Items >><<
TSLA Tesla
$1,493.85 /

-53.69 (-3.47%)

NIO NIO Inc.
$13.85 /

-1.14 (-7.61%)

JPM JPMorgan
$97.66 /

+1.35 (+1.40%)

AAPL Apple
$382.02 /

-1.54 (-0.40%)

AAPL Apple
$382.02 /

-1.54 (-0.40%)

07/13/20 Wedbush
Wedbush boosts Apple target to $450 ahead of 'massive' iPhone cycle
07/13/20 KeyBanc
Data indicates 'strong recovery' in Apple iPhone sales, says KeyBanc
07/13/20 Morgan Stanley
Apple price target raised to $419 from $340 at Morgan Stanley
07/09/20 Nomura Instinet
Nomura says Apple iPhone shipments in China pressured by 5G models in June
TSLA Tesla
$1,493.85 /

-53.69 (-3.47%)

07/14/20 Piper Sandler
Tesla price target raised to $2,322 from $939 at Piper Sandler
07/13/20
Fly Intel: Top five analyst upgrades
07/13/20 Morgan Stanley
Morgan Stanley says Tesla's 'virtually unchallenged dominance' may be near end
07/13/20 Roth Capital
Tesla upgraded to Neutral at Roth Capital as Musk prepares Indian market entry
JPM JPMorgan
$97.66 /

+1.35 (+1.40%)

07/09/20 Wolfe Research
JPMorgan upgraded to Outperform from Peer Perform at Wolfe Research
07/09/20 DA Davidson
JPMorgan upgraded to Buy from Neutral at DA Davidson
07/08/20 Seaport Global
JPMorgan initiated with a Buy at Seaport Global
06/23/20 Wells Fargo
Finicity should help MasterCard with open banking efforts, says Wells Fargo
NIO NIO Inc.
$13.85 /

-1.14 (-7.61%)

06/24/20
Fly Intel: Top five analyst downgrades
06/24/20 Goldman Sachs
NIO Inc. downgraded to Neutral from Buy at Goldman Sachs
06/09/20 86 Research
NIO Inc. initiated with a Sell at 86 Research
06/02/20 Goldman Sachs
NIO Inc. upgraded to Buy from Neutral at Goldman Sachs
TSLA Tesla
$1,493.85 /

-53.69 (-3.47%)

NIO NIO Inc.
$13.85 /

-1.14 (-7.61%)

JPM JPMorgan
$97.66 /

+1.35 (+1.40%)

AAPL Apple
$382.02 /

-1.54 (-0.40%)

  • 11
    Jun
  • 14
    Feb
TSLA Tesla
$1,493.85 /

-53.69 (-3.47%)

NIO NIO Inc.
$13.85 /

-1.14 (-7.61%)

JPM JPMorgan
$97.66 /

+1.35 (+1.40%)

AAPL Apple
$382.02 /

-1.54 (-0.40%)

TSLA Tesla
$1,493.85 /

-53.69 (-3.47%)

NIO NIO Inc.
$13.85 /

-1.14 (-7.61%)

JPM JPMorgan
$97.66 /

+1.35 (+1.40%)

AAPL Apple
$382.02 /

-1.54 (-0.40%)

TSLA Tesla
$1,493.85 /

-53.69 (-3.47%)

NIO NIO Inc.
$13.85 /

-1.14 (-7.61%)

JPM JPMorgan
$97.66 /

+1.35 (+1.40%)

AAPL Apple
$382.02 /

-1.54 (-0.40%)

TSLA Tesla
$1,493.85 /

-53.69 (-3.47%)

AAPL Apple
$382.02 /

-1.54 (-0.40%)

Conference/Events
International Society on Thrombosis & Haemostasis to hold a virtual event » 08:34
07/14/20
07/14
08:34
07/14/20
08:34
BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BMRN

BioMarin

$124.59 /

-1.47 (-1.17%)

, BMY

Bristol-Myers

$57.76 /

+0.325 (+0.57%)

, CAH

Cardinal Health

$49.85 /

+0.49 (+0.99%)

, HAE

Haemonetics

$87.92 /

-0.215 (-0.24%)

, NVO

Novo Nordisk

$65.18 /

-0.23 (-0.35%)

, PFE

Pfizer

$35.22 /

+1.38 (+4.08%)

, PTLA

Portola Pharmaceuticals

$18.01 /

+ (+0.00%)

, QURE

uniQure

$44.09 /

-2.33 (-5.02%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SMMNY

Siemens Healthineers

$0.00 /

+ (+0.00%)

, SNY

Sanofi

$50.96 /

+0.64 (+1.27%)

, TAK

Takeda Pharmaceutical

$17.10 /

-0.16 (-0.93%)

ISTH Congress 2020…

ISTH Congress 2020 Virtual Event will be held on July 12-14. Webcast Link

ShowHide Related Items >><<
TAK Takeda Pharmaceutical
$17.10 /

-0.16 (-0.93%)

SNY Sanofi
$50.96 /

+0.64 (+1.27%)

RHHBY Roche
$0.00 /

+ (+0.00%)

QURE uniQure
$44.09 /

-2.33 (-5.02%)

PTLA Portola Pharmaceuticals
$18.01 /

+ (+0.00%)

PFE Pfizer
$35.22 /

+1.38 (+4.08%)

NVO Novo Nordisk
$65.18 /

-0.23 (-0.35%)

HAE Haemonetics
$87.92 /

-0.215 (-0.24%)

CAH Cardinal Health
$49.85 /

+0.49 (+0.99%)

BMY Bristol-Myers
$57.76 /

+0.325 (+0.57%)

BMRN BioMarin
$124.59 /

-1.47 (-1.17%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
06/26/20 Deutsche Bank
Bayer price target raised to EUR 87 from EUR 85 at Deutsche Bank
06/25/20 Morgan Stanley
Bayer price target raised to EUR 88 from EUR 83 at Morgan Stanley
06/25/20 HSBC
HSBC upgrades Bayer to Buy after settlement on most Monsanto cases in U.S.
BMRN BioMarin
$124.59 /

-1.47 (-1.17%)

07/08/20 Morgan Stanley
Morgan Stanley cuts BioMarin to Equal Weight with pipeline seen better priced in
07/08/20 Morgan Stanley
BioMarin downgraded to Equal Weight from Overweight at Morgan Stanley
07/06/20 Citi
BioMarin price target raised to $148 from $105 at Citi
06/19/20 Barclays
Barclays upgrades Swedish Orphan to Equal Weight on favorable trends
BMY Bristol-Myers
$57.76 /

+0.325 (+0.57%)

06/22/20 Morgan Stanley
Morgan Stanley sees Eliquis patent being upheld, ruling being 'imminent'
06/08/20 Bernstein
Gilead, AstraZeneca merger would make sense on economic basis, says Bernstein
06/02/20 Credit Suisse
Arena Pharmaceuticals price target raised to $87 from $77 at Credit Suisse
06/02/20 Cantor Fitzgerald
Arena Pharmaceuticals price target raised to $88 from $68 at Cantor Fitzgerald
CAH Cardinal Health
$49.85 /

+0.49 (+0.99%)

06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
05/22/20 Wolfe Research
McKesson upgraded to Outperform from Peer Perform at Wolfe Research
05/15/20 UBS
McKesson, Cardinal Health upgraded to Buy from Neutral at UBS
05/15/20 UBS
Cardinal Health upgraded to Buy from Neutral at UBS
HAE Haemonetics
$87.92 /

-0.215 (-0.24%)

07/01/20 Raymond James
Haemonetics price target lowered to $113 from $125 at Raymond James
05/06/20 Barrington
Haemonetics downgraded to Market Perform from Outperform at Barrington
04/07/20 Raymond James
Haemonetics price target lowered to $130 from $150 at Raymond James
03/20/20 Jefferies
Haemonetics 'key strategic provider' for plasma COVID approaches, says Jefferies
NVO Novo Nordisk
$65.18 /

-0.23 (-0.35%)

07/06/20 BofA
Novo Nordisk downgraded to Neutral from Buy at BofA
06/05/20 JPMorgan
JPMorgan backs Overweight on Novo Nordisk after STEP data
05/18/20 Morgan Stanley
Novo Nordisk price target raised to DKK 435 from DKK 425 at Morgan Stanley
05/13/20 JPMorgan
Novo Nordisk price target raised to DKK 480 from DKK 460 at JPMorgan
PFE Pfizer
$35.22 /

+1.38 (+4.08%)

07/13/20 Canaccord
BioNTech price target raised to $75 from $60 at Canaccord
07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
PTLA Portola Pharmaceuticals
$18.01 /

+ (+0.00%)

05/07/20 Stifel
Portola deal highlights value of PhaseBio's PB2452, says Stifel
05/06/20 B. Riley FBR
B. Riley boosts CytoSorbents target, says Portola deal highlights value
05/05/20 Citi
Portola Pharmaceuticals downgraded to Neutral from Buy at Citi
05/05/20 Jefferies
Jefferies sees Portola acquisition as neutral for Alexion
QURE uniQure
$44.09 /

-2.33 (-5.02%)

06/25/20
Fly Intel: Top five analyst downgrades
06/25/20 Guggenheim
uniQure HemB deal 'not the M&A some investors were hoping for,' says Guggenheim
06/25/20 H.C. Wainwright
uniQure price target lowered to $64 from $73 at H.C. Wainwright
06/25/20 Stifel
uniQure price target lowered to $78 from $86 at Stifel
RHHBY Roche
$0.00 /

+ (+0.00%)

07/13/20 Bernstein
Roche initiated with an Outperform at Bernstein
07/03/20 AlphaValue
Roche upgraded to Add from Reduce at AlphaValue
06/29/20 Piper Sandler
Herceptin/Perjecta approval another win for Halozyme, says Piper
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
SMMNY Siemens Healthineers
$0.00 /

+ (+0.00%)

07/02/20 JPMorgan
Siemens Healthineers price target lowered to EUR 37.60 at JPMorgan
06/08/20 Citi
Siemens Healthineers upgraded to Buy from Neutral at Citi
06/05/20 Exane BNP Paribas
Siemens Healthineers downgraded to Neutral from Outperform at Exane BNP Paribas
05/26/20 Berenberg
Siemens Healthineers price target raised to EUR 52 from EUR 40 at Berenberg
SNY Sanofi
$50.96 /

+0.64 (+1.27%)

07/08/20 Piper Sandler
Piper upgrades Kiadis on 'platform validating' Sanofi deal
07/01/20 Roth Capital
Applied Genetic may attract Sanofi takeover interest, says Roth Capital
06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
TAK Takeda Pharmaceutical
$17.10 /

-0.16 (-0.93%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
SNY Sanofi
$50.96 /

+0.64 (+1.27%)

RHHBY Roche
$0.00 /

+ (+0.00%)

QURE uniQure
$44.09 /

-2.33 (-5.02%)

PTLA Portola Pharmaceuticals
$18.01 /

+ (+0.00%)

PFE Pfizer
$35.22 /

+1.38 (+4.08%)

NVO Novo Nordisk
$65.18 /

-0.23 (-0.35%)

HAE Haemonetics
$87.92 /

-0.215 (-0.24%)

CAH Cardinal Health
$49.85 /

+0.49 (+0.99%)

BMY Bristol-Myers
$57.76 /

+0.325 (+0.57%)

BMRN BioMarin
$124.59 /

-1.47 (-1.17%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

  • 06
    Sep
  • 14
    Aug
TAK Takeda Pharmaceutical
$17.10 /

-0.16 (-0.93%)

SNY Sanofi
$50.96 /

+0.64 (+1.27%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$35.22 /

+1.38 (+4.08%)

NVO Novo Nordisk
$65.18 /

-0.23 (-0.35%)

CAH Cardinal Health
$49.85 /

+0.49 (+0.99%)

BMY Bristol-Myers
$57.76 /

+0.325 (+0.57%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

SNY Sanofi
$50.96 /

+0.64 (+1.27%)

RHHBY Roche
$0.00 /

+ (+0.00%)

QURE uniQure
$44.09 /

-2.33 (-5.02%)

PTLA Portola Pharmaceuticals
$18.01 /

+ (+0.00%)

PFE Pfizer
$35.22 /

+1.38 (+4.08%)

NVO Novo Nordisk
$65.18 /

-0.23 (-0.35%)

CAH Cardinal Health
$49.85 /

+0.49 (+0.99%)

BMY Bristol-Myers
$57.76 /

+0.325 (+0.57%)

BMRN BioMarin
$124.59 /

-1.47 (-1.17%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

TAK Takeda Pharmaceutical
$17.10 /

-0.16 (-0.93%)

SNY Sanofi
$50.96 /

+0.64 (+1.27%)

QURE uniQure
$44.09 /

-2.33 (-5.02%)

PTLA Portola Pharmaceuticals
$18.01 /

+ (+0.00%)

PFE Pfizer
$35.22 /

+1.38 (+4.08%)

CAH Cardinal Health
$49.85 /

+0.49 (+0.99%)

BMY Bristol-Myers
$57.76 /

+0.325 (+0.57%)

BMRN BioMarin
$124.59 /

-1.47 (-1.17%)

Upgrade
Wayfair upgraded to Outperform at Wedbush » 08:02
07/14/20
07/14
08:02
07/14/20
08:02
W

Wayfair

$210.85 /

-12.69 (-5.68%)

As previously reported,…

As previously reported, Wedbush analyst Seth Basham upgraded Wayfair to Outperform from Neutral with a price target of $240, up from $165. Amidst the coronavirus, consumers have shifted their spending to the home goods category and to the online channel, leaving Wayfair "perfectly positioned" to capture this spending, Basham contends. Further, the analyst notes that increasing coronavirus cases are once again leading consumers to another surge in searching for and shopping at Wayfair based on Google Trends data, and the strength could persist well into 2021 given the limited potential to contain the virus with a vaccine near-term. Consumers have spent substantially on home office and outdoor furniture in recent months, but he expects home-related spending to continue to broaden in the coming months as well.

ShowHide Related Items >><<
W Wayfair
$210.85 /

-12.69 (-5.68%)

W Wayfair
$210.85 /

-12.69 (-5.68%)

07/14/20 Wedbush
Wayfair upgraded to Outperform from Neutral at Wedbush
07/07/20 Baird
Wayfair price target raised to $225 from $190 at Baird
07/01/20 Deutsche Bank
Farfetch price target raised to $23 from $17 at Deutsche Bank
06/26/20 SunTrust
Wayfair price target raised to $208 from $163 at SunTrust
W Wayfair
$210.85 /

-12.69 (-5.68%)

W Wayfair
$210.85 /

-12.69 (-5.68%)

W Wayfair
$210.85 /

-12.69 (-5.68%)

W Wayfair
$210.85 /

-12.69 (-5.68%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.